B.J. International Pvt Ltd vs National Medicines Regulatory Authority – SC / CHC / APPEAL / 38 / 2022-2025

In the matter of B.J. International Pvt Ltd and National Medicines Regulatory Authority (NMRA), the court addressed the issue of alleged malicious delay in the issuance and renewal of medical device import licenses. The court held that the delays were attributable to the Plaintiff’s own omissions and that no malice was proven against the NMRA. This decision reaffirmed the principle that actions against the NMRA require proof of bad faith, as outlined in Section 143(2) of the National Medicines Regulatory Authority Act No. 05 of 2015. The appeal was dismissed, affirming the Commercial High Court’s judgment.

A.H.M.D. Nawaz, J. – The main judgment affirmed the Commercial High Court’s dismissal of the Plaintiff-Appellant’s action against the National Medicines Regulatory Authority (NMRA) for